Mercados españoles cerrados

WuXi AppTec Co., Ltd. (WUXIF)

OTC Markets OTCPK - OTC Markets OTCPK Precio demorado. Divisa en USD
Añadir a la lista de favoritos
4,85000,0000 (0,00%)
Al cierre: 03:06PM EDT

WuXi AppTec Co., Ltd.

288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai 200131
China
86 21 5046 1111
https://www.wuxiapptec.com

Sector(es)Healthcare
SectorDiagnostics & Research
Empleados a tiempo completo41.116

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Dr. Ge Li Ph.D.Co-Founder, Chairman, President & CEO5,91MN/A1967
Dr. Minzhang Chen Ph.D.Co-CEO & Executive Director1,54MN/A1969
Dr. Qing Yang Ph.D.Co-CEO & Executive Director1,07MN/A1969
Dr. Edward Hu M.B.A.Vice Chairman, Global Chief Investment Officer, CEO of WuXi ATU & Head of DDSU1,18MN/A1962
Ms. Ming ShiSenior VP & CFON/AN/A1974
Mr. Zhaohui ZhangCOO of China, Executive VP & Executive Director991,51kN/A1969
Mr. Yuanzhou ZhangJoint Company SecretaryN/AN/A1988
Mr. Ruijia TangIR DirectorN/AN/AN/A
Dr. Jingchao Dong Ph.D.Senior VP & Head of RCSN/AN/AN/A
Mr. Tao Guo Ph.D.Senior VP and Head of RCS BD&IPMN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; and drug discovery services to pharmaceutical and biotech customers. In addition, the company offers consulting services for combinatorial chemistry and pharmaceuticals; and develops computer software and databases. Further, it is involved in pharmaceutical research and development; pharmacology, toxicology, and safety evaluation research services; and new drug clinical development and on-site management services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Gobierno corporativo

El ISS Governance QualityScore de WuXi AppTec Co., Ltd., a día 1 de junio de 2024, es 3. Las puntuaciones base son Auditoría: 7; Tablero: 2; Derechos de los accionistas: 9; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.